Concepts (199)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Organ Transplantation | 14 | 2021 | 2616 | 1.95 | Why? |
| Transplant Recipients | 15 | 2021 | 4982 | 0.99 | Why? |
| Cytomegalovirus | 5 | 2019 | 600 | 0.97 | Why? |
| Cytomegalovirus Infections | 5 | 2019 | 667 | 0.89 | Why? |
| Antibiotic Prophylaxis | 3 | 2018 | 399 | 0.76 | Why? |
| Toxoplasmosis | 1 | 2018 | 59 | 0.71 | Why? |
| Tissue Donors | 5 | 2021 | 1679 | 0.60 | Why? |
| Donor Selection | 2 | 2020 | 804 | 0.46 | Why? |
| Lung Transplantation | 3 | 2019 | 1554 | 0.45 | Why? |
| RNA Viruses | 1 | 2019 | 824 | 0.45 | Why? |
| Travel-Related Illness | 1 | 2018 | 1357 | 0.41 | Why? |
| Graft Rejection | 2 | 2018 | 1766 | 0.39 | Why? |
| Anti-Infective Agents | 1 | 2019 | 1766 | 0.33 | Why? |
| Vaccination | 4 | 2021 | 19050 | 0.31 | Why? |
| Bronchiolitis Obliterans | 2 | 2019 | 86 | 0.29 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2018 | 2426 | 0.27 | Why? |
| Respiratory Tract Infections | 3 | 2019 | 6817 | 0.24 | Why? |
| Influenza Vaccines | 1 | 2018 | 2941 | 0.23 | Why? |
| Switzerland | 8 | 2021 | 2738 | 0.22 | Why? |
| Practice Guidelines as Topic | 5 | 2019 | 15421 | 0.22 | Why? |
| Immunocompromised Host | 5 | 2021 | 5150 | 0.21 | Why? |
| Antilymphocyte Serum | 1 | 2019 | 80 | 0.19 | Why? |
| Daptomycin | 1 | 2019 | 64 | 0.19 | Why? |
| Bacteriuria | 1 | 2018 | 31 | 0.19 | Why? |
| Leukocyte Immunoglobulin-like Receptor B1 | 1 | 2018 | 11 | 0.19 | Why? |
| Vaccines | 1 | 2018 | 3692 | 0.18 | Why? |
| Eukaryota | 1 | 2018 | 31 | 0.18 | Why? |
| Postoperative Complications | 5 | 2020 | 5861 | 0.18 | Why? |
| Toxocariasis | 1 | 2017 | 2 | 0.18 | Why? |
| HLA-G Antigens | 1 | 2018 | 48 | 0.18 | Why? |
| Kidney Transplantation | 4 | 2019 | 5397 | 0.18 | Why? |
| Interferon beta-1a | 1 | 2020 | 316 | 0.17 | Why? |
| Cephalosporins | 1 | 2019 | 250 | 0.17 | Why? |
| Lymphoproliferative Disorders | 1 | 2018 | 110 | 0.16 | Why? |
| Pneumocystis carinii | 1 | 2018 | 205 | 0.16 | Why? |
| Aspergillus | 1 | 2019 | 347 | 0.15 | Why? |
| Metagenome | 1 | 2018 | 268 | 0.15 | Why? |
| Bone and Bones | 1 | 2018 | 235 | 0.15 | Why? |
| Latin America | 2 | 2018 | 1721 | 0.15 | Why? |
| Liver Failure | 1 | 2018 | 266 | 0.14 | Why? |
| Capsid Proteins | 1 | 2018 | 365 | 0.14 | Why? |
| Travel Medicine | 1 | 2018 | 335 | 0.14 | Why? |
| Endocarditis | 1 | 2019 | 368 | 0.13 | Why? |
| Pneumonia, Pneumocystis | 1 | 2018 | 322 | 0.13 | Why? |
| Endemic Diseases | 1 | 2018 | 480 | 0.13 | Why? |
| Tissue and Organ Procurement | 2 | 2021 | 1277 | 0.12 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 1 | 2019 | 711 | 0.12 | Why? |
| Anti-Bacterial Agents | 3 | 2019 | 10083 | 0.12 | Why? |
| Antigens, CD | 1 | 2018 | 984 | 0.12 | Why? |
| Neglected Diseases | 1 | 2017 | 381 | 0.12 | Why? |
| Liver Transplantation | 2 | 2018 | 2864 | 0.12 | Why? |
| Urinary Tract Infections | 1 | 2018 | 534 | 0.12 | Why? |
| Antiviral Agents | 4 | 2020 | 41703 | 0.11 | Why? |
| Drug Administration Schedule | 1 | 2018 | 2324 | 0.11 | Why? |
| Polymorphism, Genetic | 1 | 2018 | 1074 | 0.10 | Why? |
| Immunization Schedule | 1 | 2018 | 1305 | 0.10 | Why? |
| Staphylococcal Infections | 1 | 2019 | 1099 | 0.10 | Why? |
| Humans | 37 | 2021 | 930598 | 0.10 | Why? |
| Bronchoscopy | 1 | 2016 | 991 | 0.09 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2018 | 1234 | 0.09 | Why? |
| Follow-Up Studies | 4 | 2020 | 17020 | 0.09 | Why? |
| Transplants | 2 | 2020 | 136 | 0.08 | Why? |
| Europe | 3 | 2018 | 12702 | 0.08 | Why? |
| Bacteria | 1 | 2018 | 1897 | 0.08 | Why? |
| Immunosuppressive Agents | 4 | 2019 | 6331 | 0.08 | Why? |
| Risk Factors | 8 | 2020 | 71621 | 0.08 | Why? |
| Adult | 16 | 2021 | 244371 | 0.08 | Why? |
| Adenosine Monophosphate | 2 | 2021 | 5652 | 0.08 | Why? |
| Alanine | 2 | 2021 | 5687 | 0.08 | Why? |
| Virus Replication | 2 | 2018 | 14331 | 0.08 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.08 | Why? |
| Vitamin D | 2 | 2018 | 2904 | 0.08 | Why? |
| Middle Aged | 15 | 2020 | 270681 | 0.07 | Why? |
| Influenza, Human | 2 | 2021 | 10779 | 0.07 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2018 | 3607 | 0.07 | Why? |
| Antibody Formation | 1 | 2018 | 4038 | 0.07 | Why? |
| Bacterial Infections | 1 | 2018 | 2229 | 0.07 | Why? |
| Viruses | 1 | 2018 | 2238 | 0.07 | Why? |
| Female | 20 | 2021 | 380317 | 0.07 | Why? |
| Male | 19 | 2020 | 367725 | 0.07 | Why? |
| MicroRNAs | 1 | 2017 | 1787 | 0.07 | Why? |
| Multivariate Analysis | 3 | 2020 | 5440 | 0.06 | Why? |
| Community-Acquired Infections | 2 | 2019 | 2328 | 0.06 | Why? |
| Genetic Predisposition to Disease | 1 | 2018 | 4027 | 0.06 | Why? |
| Zoonoses | 1 | 2017 | 3034 | 0.06 | Why? |
| Lung Diseases | 1 | 2016 | 2361 | 0.06 | Why? |
| Practice Patterns, Physicians' | 2 | 2018 | 4927 | 0.06 | Why? |
| Aged | 10 | 2021 | 215776 | 0.06 | Why? |
| Societies, Medical | 1 | 2019 | 6907 | 0.06 | Why? |
| Retrospective Studies | 5 | 2020 | 105322 | 0.05 | Why? |
| Prospective Studies | 7 | 2020 | 43301 | 0.05 | Why? |
| Fosfomycin | 1 | 2019 | 48 | 0.05 | Why? |
| Logistic Models | 3 | 2020 | 9089 | 0.05 | Why? |
| Young Adult | 6 | 2020 | 93724 | 0.05 | Why? |
| Asymptomatic Infections | 1 | 2018 | 7218 | 0.05 | Why? |
| Intention to Treat Analysis | 1 | 2020 | 673 | 0.05 | Why? |
| Procollagen | 1 | 2018 | 29 | 0.05 | Why? |
| Respiration, Artificial | 2 | 2020 | 22116 | 0.05 | Why? |
| DNA, Ribosomal | 1 | 2018 | 112 | 0.05 | Why? |
| Interleukin-2 Receptor alpha Subunit | 1 | 2019 | 234 | 0.04 | Why? |
| Collagen Type I | 1 | 2018 | 56 | 0.04 | Why? |
| Toxocara | 1 | 2017 | 2 | 0.04 | Why? |
| Bone Remodeling | 1 | 2018 | 59 | 0.04 | Why? |
| Parathyroid Hormone | 1 | 2018 | 98 | 0.04 | Why? |
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2018 | 170 | 0.04 | Why? |
| Albendazole | 1 | 2017 | 32 | 0.04 | Why? |
| Gene-Environment Interaction | 1 | 2018 | 127 | 0.04 | Why? |
| Heterozygote | 1 | 2018 | 249 | 0.04 | Why? |
| Homozygote | 1 | 2018 | 230 | 0.04 | Why? |
| Immediate-Early Proteins | 1 | 2017 | 44 | 0.04 | Why? |
| Phosphates | 1 | 2018 | 135 | 0.04 | Why? |
| Host-Pathogen Interactions | 1 | 2018 | 11041 | 0.04 | Why? |
| Poisson Distribution | 1 | 2018 | 348 | 0.04 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.04 | Why? |
| Infectious Disease Medicine | 1 | 2020 | 311 | 0.04 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.04 | Why? |
| Compassionate Use Trials | 1 | 2021 | 632 | 0.04 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.04 | Why? |
| Pneumonia | 1 | 2016 | 5652 | 0.04 | Why? |
| Drug Synergism | 1 | 2019 | 833 | 0.04 | Why? |
| Diabetes Mellitus | 1 | 2018 | 8207 | 0.04 | Why? |
| Treatment Outcome | 3 | 2018 | 51732 | 0.04 | Why? |
| Pregnancy Complications, Infectious | 1 | 2021 | 11559 | 0.04 | Why? |
| Inflammation | 1 | 2018 | 13255 | 0.04 | Why? |
| Risk Assessment | 2 | 2018 | 25439 | 0.04 | Why? |
| Incidence | 4 | 2020 | 25622 | 0.04 | Why? |
| Bone Density | 1 | 2018 | 335 | 0.04 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.03 | Why? |
| Treatment Failure | 1 | 2020 | 2106 | 0.03 | Why? |
| Eosinophilia | 1 | 2017 | 292 | 0.03 | Why? |
| HeLa Cells | 1 | 2017 | 1303 | 0.03 | Why? |
| Tertiary Care Centers | 2 | 2021 | 8248 | 0.03 | Why? |
| Lymphoma | 1 | 2018 | 522 | 0.03 | Why? |
| Fractures, Bone | 1 | 2018 | 487 | 0.03 | Why? |
| Cell Line | 2 | 2018 | 12040 | 0.03 | Why? |
| Glomerular Filtration Rate | 1 | 2018 | 1262 | 0.03 | Why? |
| Kaplan-Meier Estimate | 1 | 2020 | 4260 | 0.03 | Why? |
| Regression Analysis | 1 | 2018 | 2484 | 0.03 | Why? |
| Microbial Sensitivity Tests | 1 | 2019 | 2886 | 0.03 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.03 | Why? |
| Interferon-gamma | 1 | 2019 | 2711 | 0.02 | Why? |
| Sequence Analysis, DNA | 1 | 2018 | 2830 | 0.02 | Why? |
| Adolescent | 4 | 2020 | 86841 | 0.02 | Why? |
| Pregnant Women | 1 | 2021 | 2535 | 0.02 | Why? |
| Pennsylvania | 1 | 2010 | 558 | 0.02 | Why? |
| Hospitals, University | 1 | 2020 | 4173 | 0.02 | Why? |
| Transcriptome | 1 | 2021 | 3466 | 0.02 | Why? |
| Killer Cells, Natural | 1 | 2018 | 2093 | 0.02 | Why? |
| Health Care Surveys | 1 | 2017 | 2942 | 0.02 | Why? |
| Cross-Sectional Studies | 3 | 2021 | 53120 | 0.02 | Why? |
| Electronic Health Records | 1 | 2020 | 3492 | 0.02 | Why? |
| Forced Expiratory Volume | 1 | 2010 | 632 | 0.02 | Why? |
| Leukocytes, Mononuclear | 1 | 2017 | 2115 | 0.02 | Why? |
| Peptide Fragments | 1 | 2018 | 2075 | 0.02 | Why? |
| DNA, Viral | 1 | 2017 | 2521 | 0.02 | Why? |
| Infant | 2 | 2021 | 30274 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2020 | 7268 | 0.02 | Why? |
| Odds Ratio | 1 | 2018 | 5861 | 0.02 | Why? |
| Bronchoalveolar Lavage | 1 | 2010 | 603 | 0.02 | Why? |
| Immunity, Cellular | 1 | 2019 | 3614 | 0.02 | Why? |
| Comorbidity | 2 | 2021 | 34796 | 0.02 | Why? |
| Peptides | 1 | 2018 | 2513 | 0.02 | Why? |
| International Cooperation | 1 | 2019 | 3436 | 0.02 | Why? |
| Decision Making | 1 | 2020 | 3132 | 0.02 | Why? |
| Survival Rate | 1 | 2020 | 9206 | 0.02 | Why? |
| Vulnerable Populations | 1 | 2020 | 3099 | 0.02 | Why? |
| Cohort Studies | 2 | 2019 | 36005 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.02 | Why? |
| Vitamin D Deficiency | 1 | 2018 | 1782 | 0.02 | Why? |
| Guideline Adherence | 1 | 2017 | 2309 | 0.02 | Why? |
| Hospitalization | 3 | 2020 | 54280 | 0.02 | Why? |
| Serologic Tests | 1 | 2017 | 4359 | 0.02 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.02 | Why? |
| RNA, Messenger | 1 | 2017 | 5131 | 0.01 | Why? |
| Diagnosis, Differential | 1 | 2016 | 7220 | 0.01 | Why? |
| Mortality | 1 | 2018 | 7132 | 0.01 | Why? |
| Time Factors | 2 | 2018 | 31397 | 0.01 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2010 | 2309 | 0.01 | Why? |
| Biopsy | 1 | 2010 | 2811 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.01 | Why? |
| Adrenal Cortex Hormones | 1 | 2017 | 6537 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2020 | 88759 | 0.01 | Why? |
| Pregnancy | 1 | 2021 | 23879 | 0.01 | Why? |
| Phylogeny | 1 | 2018 | 13341 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 11367 | 0.01 | Why? |
| Coinfection | 1 | 2018 | 6820 | 0.01 | Why? |
| Acute Disease | 1 | 2010 | 6029 | 0.01 | Why? |
| Viral Load | 1 | 2017 | 15850 | 0.01 | Why? |
| Hospital Mortality | 1 | 2020 | 22087 | 0.01 | Why? |
| Global Health | 1 | 2020 | 13911 | 0.01 | Why? |
| Prevalence | 1 | 2017 | 25773 | 0.01 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.01 | Why? |
| Child, Preschool | 1 | 2018 | 36283 | 0.01 | Why? |
| Population Surveillance | 1 | 2010 | 4967 | 0.01 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2018 | 43792 | 0.01 | Why? |
| Child | 1 | 2018 | 70012 | 0.01 | Why? |
| Animals | 1 | 2017 | 78931 | 0.01 | Why? |
Manuel's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(199)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(224)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_